Neratinib as adjuvant therapy in patients with HER2 positive breast cancer: expert opinion.
Future Oncol
; 19(24): 1695-1708, 2023 08.
Article
in En
| MEDLINE
| ID: mdl-37605877
Key words
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Breast Neoplasms
Type of study:
Prognostic_studies
Limits:
Female
/
Humans
Language:
En
Journal:
Future Oncol
Year:
2023
Document type:
Article
Affiliation country:
Italy
Country of publication:
United kingdom